Tirzepatide better than glargine for improving kidney outcomes in type 2 diabetes: SURPASS-4 trial Medha Baranwal3 Oct 2022 6:00 PM ISTUSA: Tirzepatide slows the estimated glomerular filtration rate (eGFR) decline and reduces the urine albumin-creatinine ratio (UACR) in type 2...
EASD Highlights Isra Zaman24 Sept 2022 9:45 AM ISTType 2 diabetes worst affects life expectancy of women, younger people and smokers: ResearchNew research presented at the annual meeting of the...
Tirzepatide, potential new treatment for inadequately controlled type 2 diabetes patients: Lancet Medha Baranwal8 Aug 2022 12:00 PM ISTJapan: New research shows tirzepatide to be a potential new treatment option for type 2 diabetes that is not controlled well with a single oral...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 9:15 AM ISTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
Tirzepatide new treatment option for people who are overweight or have obesity: SURMOUNT-1 clinical trial Dr. Kamal Kant Kohli6 Jun 2022 9:45 AM ISTIn the 72-week, phase III SURMOUNT-1 clinical trial the researchers have reported that combination GIP and GLP-1 receptor agonist tirzepatide...
Tirzepatide shows superior outcomes in type 2 diabetes without increasing hypoglycemia risk Medha Baranwal23 May 2022 8:00 PM ISTGreece: All doses of tirzepatide were found to be superior to placebo, insulin, and long-acting GLP-1 RAs in reducing HbA1c and body weight, according...
'Twincretin' Tirzepatide Recieves FDA Approval for Type 2 Diabetes Dr. Nandita Mohan18 May 2022 10:30 AM ISTThe "Twincretin" era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration's (FDA's) approval...
Eli Lilly Mounjaro injection gets USFDA nod for type 2 diabetes Ruchika Sharma14 May 2022 3:17 PM ISTMounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in Lilly's auto-injector pen with a pre-attached,...
FDA approves Tirzepatide for controlling blood sugar in type 2 diabetes patients Dr. Kamal Kant Kohli14 May 2022 12:15 PM ISTThe US Food and Drug Administratio has granted approval to tirzepatide (Mounjaro) injection for treatment of patients with type 2 diabetes. ...
Journal Club - Tirzepatide may lead weight loss of up to 23 percent in obese people Dr.B.P.RAHUL9 May 2022 3:33 PM ISTRecent data from SURMOUNT-1 clinical trial showed that tirzepatide achieved superior weight loss compared to a placebo in obese/overweight individuals...
Tirzepatide may lead weight loss of up to 23 percent in obese people: SURMOUNT-1 trial Medha Baranwal3 May 2022 10:00 AM ISTUSA: Recent data from SURMOUNT-1 clinical trial showed that tirzepatide achieved superior weight loss compared to a placebo in obese/overweight...
Tirzepatide tied with Significant Reduction in Liver Fat Content in Patients with T2D: Study Dr. Shravani Dali30 April 2022 11:00 AM ISTTirzepatide Shows a Significant Reduction in Liver Fat Content in Patients with T2D, according to a recent study published in The Lancet Diabetes...
